4.7 Article

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets

Journal

CANCER LETTERS
Volume 317, Issue 2, Pages 207-217

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.11.026

Keywords

Ovarian cancer; Cancer cell invasion; Vasculogenic mimicry; Stat3; Rho; IGF; IGF-IR

Categories

Funding

  1. Ministere de l'Enseignement Superieur et de la Recherche
  2. Ligue Departementale de l'Eure contre le Cancer
  3. Association Ti'toine
  4. Groupement des Entreprises Francaises dans la Lutte contre le Cancer de Rouen (GEFLUC of Rouen)
  5. Ligue Regionale de Haute Normandie contre le Cancer

Ask authors/readers for more resources

Seeking to improve ovarian cancer therapy, we compared biological characteristics of the moderately-aggressive OVCAR-3 cell line with two highly aggressive ovarian cancer cell populations: the SK-OV-3 cell line, and HASCJ primary cells isolated from the ascitic fluid of a patient with FIGO stage IV ovarian cancer. Secretion of angiogenic factors was not discriminative, whereas cell invasion through Matrigel and vasculogenic mimicry were much greater in the more aggressive cells. Among 10 agents tested for their ability to decrease cancer cell aggressivity using these two models, inhibitors of Stat3, IGF-IR and Rho GTPase were found to be the most promising. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available